Dr Reddy's Laboratories: Q3 Earnings Insights - Dr Reddy's Laboratories (NYSE:RDY)

Dr Reddy's Laboratories RDY reported its Q3 earnings results on Tuesday, January 30, 2024 at 01:30 PM.

Here's what investors need to know about the announcement.

Dr Reddy's Laboratories beat estimated earnings by 25.32%, reporting an EPS of $0.99 versus an estimate of $0.79.

Revenue was up $42.39 million from the same period last year.

Last quarter the company beat on EPS by $0.23 which was followed by a 0.7% increase in the share price the next day.

Here's a look at Dr Reddy's Laboratories's past performance:

Quarter	Q2 2024	Q1 2024	Q4 2023	Q3 2023
EPS Estimate	0.84	0.70	0.64	0.58
EPS Actual	1.07	1.03	0.70	0.91
Revenue Estimate	819.33M	783.68M	742.18M	699.00M
Revenue Actual	828.00M	821.00M	766.00M	824.61M

To track all earnings releases for Dr Reddy's Laboratories visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.